Jefferies Financial Group Inc. Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 3,605,067 shares of the company’s stock, valued at approximately $106,458,000. Acadia Healthcare makes up 0.7% of Jefferies Financial Group Inc.’s investment portfolio, making the stock its 12th biggest holding.

A number of other institutional investors also recently modified their holdings of ACHC. Public Employees Retirement System of Ohio acquired a new stake in Acadia Healthcare in the second quarter valued at about $144,000. Corient Private Wealth LP acquired a new position in Acadia Healthcare during the second quarter worth about $700,000. Bank of America Corp DE bought a new position in shares of Acadia Healthcare in the second quarter worth about $21,606,000. Freestone Grove Partners LP bought a new position in shares of Acadia Healthcare in the second quarter worth about $19,002,000. Finally, Man Group plc acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $7,534,000.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $30.22 on Friday. The business has a 50 day moving average of $30.39 and a 200-day moving average of $26.04. The company has a market capitalization of $2.81 billion, a P/E ratio of -2.43, a P/E/G ratio of 9.85 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same period last year, the company earned $0.83 EPS. The firm’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on ACHC. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research note on Monday, May 4th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Finally, Barclays increased their price target on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.